How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic?  

When a PCP calls with concern for GCA and is wondering whether to start empiric steroids what data do you prioritize to make that decision and do you apply a scoring system such as GCAPS?

This question is part of a collaboration with RheumMadness and is specifically in reference to: GCA Fast Track



Answer from: at Academic Institution

Answer from: at Academic Institution

Answer from: at Community Practice